Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|December 5, 2017
Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drugTina Kauss, Alexandra Gaubert, Luc Tabaran, et al.
Data in Brief|November 22, 2017
Data on iron oxide core oil-in-water nanoemulsions for atherosclerosis imagingGeoffrey Prévot, Stéphane Mornet, Cyril Lorenzato, et al.
Pharmaceutics|February 26, 2022
Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing BacteriaPhuoc Vinh Nguyen, Clémentine Aubry, Narimane Boudaoud, et al.
Biochemical Pharmacology|September 9, 2006
Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediatorsMaria Mamani-Matsuda, Tina Kauss, Abir Al-Kharrat, et al.
Organic & Biomolecular Chemistry|March 12, 2026
Glycosyl modified nucleoside motifs for glycoconjugation of oligonucleotidesBiju Majumdar, Haythem Abda, Henri Barry, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 25, 2017
Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulationsTina Kauss, Mathieu Marchivie, Thida Phoeung, et al.
Plos One|March 13, 2009
Molecular blocking of CD23 supports its role in the pathogenesis of arthritisJérôme Rambert, Maria Mamani-Matsuda, Daniel Moynet, et al.
Infection and Immunity|October 7, 2009
CD23 mediates antimycobacterial activity of human macrophagesM Djavad Mossalayi, Ioannis Vouldoukis, Maria Mamani-Matsuda, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2018
Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable SolutionsBoubakar Ba, Karen Gaudin, Amélie Désiré, et al.
Pageof 3